Structure of enzyme unravelled providing basis for more accurate design of chemotherapeutic drugs

November 15, 2012

A group of researchers at the University of California, Berkeley have for the first time described the structure of the active site core of topoisomerase II alpha, an important target for anti-cancer drugs.

The type II topoisomerases are important enzymes that are involved in maintaining the and during both replication and transcription of DNA. One of these enzymes, topoisomerase II alpha, is involved in the replication of DNA and , and is highly expressed in rapidly dividing . As such, this enzyme is the primary target of chemotherapeutic small such as etoposide. A major drawback to the use of these drugs is their association with secondary malignancies in some patients—a side effect believed to be caused by a cross-reaction with topoisomerase II beta, another member of this family that is involved in DNA transcription.

In their study the group of researchers, led by Professor James Berger, report securing the structure of the active site core of topoisomerase II alpha in complex with DNA. They describe the conformational changes undergone by the enzyme during and cleavage. While the structure of etoposide-inhibited topoisomerase II beta has been previously established by others, this is the first time similar structural information has been available for topoisomerase II alpha. Comparing the structures of these enzymes could assist in the design of more specific etoposide-like drugs, and reduce the risk of secondary malignancies.

"We hope this work will lead to an improved understanding of the mechanisms by which select small-molecule agents inhibit type II topoisomerase function, as well as help guide the development of new or improved antibacterial and anticancer drugs against enzymes of this class," said Professor Berger.

In a commentary accompanying the article, Professor N. Patrick Higgins of the University of Alabama, states that, together with the previously published structure of topoisomerase II beta, "...these two structures provide key information that will be relevant to understanding how these closely related proteins perform different roles during cell growth and tissue development. The newly described structure could also provide the basis for the design of more selective drugs, with a lower risk of side effects."

Explore further: DNA with a twist: New company to search for cancer drugs and antibiotics

More information: The article is "The Structure of DNA-Bound Human Topoisomerase II Alpha: Conformational Mechanisms for Coordinating Inter-Subunit Interactions with DNA Cleavage" by Timothy J. Wendorff, Bryan H. Schmidt, Pauline Heslop, Caroline A. Austin, and James M. Berger (doi:10.1016/j.jmb.2012.07.014). The article appears in Journal of Molecular Biology, Volume 424, Issue 3-4, pages 109 (7 December 2012)

Related Stories

Preventing cells from getting the kinks out of DNA

May 21, 2010

(PhysOrg.com) -- Many standard antibiotics and anti-cancer drugs block the enzymes that snip the kinks and knots out of DNA -DNA tangles are lethal to cells - but the drugs are increasingly encountering resistant bacteria ...

Nanotweezers Unlock Anticancer Drug Secrets

August 22, 2007

The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller’s motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led ...

Stop and go: How the cell deals with transcriptional roadblocks

February 23, 2011

Gene transcription is central to cell function, as it converts the information stored in the DNA into RNA molecules of defined sequence, which then program protein synthesis. The enzyme RNA polymerase II (Pol II) is responsible ...

Recommended for you

Canada conservationist warns of 'cyber poaching'

February 25, 2017

Photographers, poachers and eco-tour operators are in the crosshairs of a Canadian conservationist who warns that tracking tags are being hacked and misused to harass and hunt endangered animals.

How proteins reshape cell membranes

February 24, 2017

Small "bubbles" frequently form on membranes of cells and are taken up into their interior. The process involves EHD proteins - a focus of research by Prof. Oliver Daumke of the MDC. He and his team have now shed light on ...

Neanderthal DNA contributes to human gene expression

February 23, 2017

The last Neanderthal died 40,000 years ago, but much of their genome lives on, in bits and pieces, through modern humans. The impact of Neanderthals' genetic contribution has been uncertain: Do these snippets affect our genome's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.